论文部分内容阅读
The point mutations in the active-site arginine residues of isocitrate dehydrogenase(IDH)(IDH1/R132,IDH2/R140,and IDH2/R172)occur frequently in a variety of cancers,including acute myeloid leukemia(AML),brain tumors,and holangiocarcinomas